1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2027

Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2027

  • December 2017
  • 162 pages
  • ID: 5308402
  • Format: PDF
  • By Visiongain

Summary

Table of Contents

Antifibrotics, Tyrosine Kinase Inhibitors, Anti-inflammatory Drugs, Immunosuppressants, Other MoA, Innovator Drugs, Off-label Drugs

Report Details
The global anti-idiopathic pulmonary fibrosis drugs market is expected to grow at a CAGR of 16.7% in the first half of the forecast period. In 2016, the anti-fibrotics held the largest market share (52%) followed by the tyrosine kinase inhibitors.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 162-page report you will receive 57 tables and 97 figures– all unavailable elsewhere.
The 162-page report provides clear detailed insight into the global anti-idiopathic pulmonary fibrosis drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• Global Anti-Idiopathic Pulmonary Fibrosis Drugs market forecasts to 2027

This report also breaks down the revenue forecast for the global anti-idiopathic pulmonary fibrosis drugs market by mechanism of action:
- Antifibrotics
- Tyrosine Kinase Inhibitors
- Anti-inflammatory Drugs
- Immunosuppressants
- Other MoA

This report also breaks down the revenue forecast for the global anti-idiopathic pulmonary fibrosis drugs market by Innovator and Off-label drugs:
- Innovator Drugs
- Off-label Drugs

This report provides individual revenue forecasts to 2027 for these regional and national markets:
- US
- Japan
- EU5: Germany, France, the UK, Italy, Spain
- Rest of Europe
- Rest of World

This report provides individual revenue forecasts to 2027 for these marketed drugs:
- Esbriet
- Ofev

Our study gives qualitative analysis of the anti-idiopathic pulmonary fibrosis drugs market. It discusses:
- Diagnosed Prevalence of Idiopathic Pulmonary Fibrosis in the G7 markets (Historical 2010-2015, 2016 data, Forecast 2017-2027)
- Epidemiology of Idiopathic Pulmonary Fibrosis by disease severity
- Epidemiology of Idiopathic Pulmonary Fibrosis by gender
- Discussion on novel clinical molecules under development for the treatment of Idiopathic Pulmonary Fibrosis
- Pricing and Reimbursement Overview on Ofev and Esbriet (by NICE, SMC, PBAC, CADTH, G-BA, HAS)
- A SWOT Analysis on the anti-idiopathic pulmonary fibrosis drugs market

Our study discusses the marketed anti-idiopathic pulmonary fibrosis drugs and pipeline anti-idiopathic pulmonary fibrosis drugs from these companies:
- Actelion
- Afferent Pharmaceuticals
- Asahi Kasei Pharma
- Bellerophon Therapeutics
- Biogen
- Boehringer Ingelheim
- FibroGen
- Galapagos
- Galecto Biotech
- Genentech
- Global Blood Therapeutics
- GSK
- Kadmon Pharmaceuticals
- LTT Bio-Pharma
- MediciNova
- Merck
- Moerae
- Pacific Therapeutics
- Promedior
- ProMetic Life Sciences
- Roche
- Sanofi
- Teva
- Zai Lab

Visiongain’s study is intended for anyone requiring commercial analyses for the global Anti-Idiopathic Pulmonary Fibrosis Drugs Market. You find data, trends and predictions.
Buy our report today Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2027: Antifibrotics, Tyrosine Kinase Inhibitors, Anti-inflammatory Drugs, Immunosuppressants, Other MoA, Innovator Drugs, Off-label Drugs.

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Vascular Grafts - Medical Devices Pipeline Assessment, 2019

Vascular Grafts - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Vascular Grafts - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Vascular Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Vascular Grafts ...

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020" provides ...

Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025

Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025

  • $ 3500
  • February 2020

The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019–2025.The following factors are likely to contribute to the growth of the transplant diagnostics ...


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on